Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transrectal versus transperineal prostate fusion biopsy: a pair-matched analysis to evaluate accuracy and complications.
Oderda M, Diamand R, Abou Zahr R, Anract J, Assenmacher G, Barry Delongchamps N, Bui AP, Benamran D, Calleris G, Dariane C, Ferriero M, Fiard G, Taha F, Fourcade A, Fournier G, Guenzel K, Halinski A, Marra G, Ploussard G, Rysankova K, Roche JB, Simone G, Windisch O, Gontero P. Oderda M, et al. Among authors: assenmacher g. World J Urol. 2024 Sep 25;42(1):535. doi: 10.1007/s00345-024-05245-1. World J Urol. 2024. PMID: 39320521 Free PMC article.
Refining clinically relevant cut-offs of prostate specific antigen density for risk stratification in patients with PI-RADS 3 lesions.
Mjaess G, Haddad L, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Abou Zahr R, Ploussard G, Fiard G, Halinski A, Rysankova K, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Bui AP, Taha F, Windisch O, Benamran D, Assenmacher G, Benijts J, Guenzel K, Roumeguère T, Peltier A, Diamand R. Mjaess G, et al. Among authors: assenmacher g. Prostate Cancer Prostatic Dis. 2024 Jul 24. doi: 10.1038/s41391-024-00872-6. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 39048664
External validation and comparison of magnetic resonance imaging-based risk prediction models for prostate biopsy stratification.
Diamand R, Guenzel K, Jabbour T, Baudewyns A, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A. Diamand R, et al. Among authors: assenmacher g. World J Urol. 2024 Jun 12;42(1):372. doi: 10.1007/s00345-024-05068-0. World J Urol. 2024. PMID: 38866949
The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.
Baudewyns A, Guenzel K, Halinski A, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Jabbour T, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Zahr RA, Ploussard G, Fiard G, Rysankova K, Bui AP, Taha F, Windisch O, Benamran D, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A, Diamand R. Baudewyns A, et al. Among authors: assenmacher g. World J Urol. 2024 May 15;42(1):322. doi: 10.1007/s00345-024-04962-x. World J Urol. 2024. PMID: 38747982
Transperineal or Transrectal Magnetic Resonance Imaging-targeted Biopsy for Prostate Cancer Detection.
Diamand R, Guenzel K, Mjaess G, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Bui AP, Taha F, Oderda M, Gontero P, Rysankova K, Bernal-Gomez A, Mastrorosa A, Roche JB, Fiard G, Abou Zahr R, Ploussard G, Windisch O, Novello Q, Benamran D, Delavar G, Anract J, Barry Delongchamps N, Halinski A, Dariane C, Benijts J, Assenmacher G, Roumeguère T, Peltier A. Diamand R, et al. Among authors: assenmacher g. Eur Urol Focus. 2024 Sep;10(5):805-811. doi: 10.1016/j.euf.2024.03.003. Epub 2024 Mar 19. Eur Urol Focus. 2024. PMID: 38508895
The Added Value of Side-specific Systematic Biopsy in Patients Diagnosed by Magnetic Resonance Imaging-targeted Prostate Biopsy.
Bourgeno HA, Jabbour T, Baudewyns A, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Abou Zahr R, Ploussard G, Fiard G, Halinski A, Rysankova K, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Bui AP, Taha F, Windisch O, Benamran D, Assenmacher G, Vlahopoulos L, Guenzel K, Roumeguère T, Peltier A, Diamand R. Bourgeno HA, et al. Among authors: assenmacher g. Eur Urol Oncol. 2024 Jan 24:S2588-9311(24)00031-2. doi: 10.1016/j.euo.2024.01.007. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38272745
Prognostic significance of PI-RADS 5 lesions in patients treated by radical prostatectomy.
Fiard G, Seigneurin A, Roumiguié M, Albisinni S, Anract J, Assenmacher G, Barry Delongchamps N, Dariane C, Feyaerts A, Fourcade A, Fournier G, Gontero P, Mastroianni R, Oderda M, Peltier A, Roumeguère T, Saussez T, Simone G, Van Damme J, Descotes JL, Ploussard G, Diamand R. Fiard G, et al. Among authors: assenmacher g. World J Urol. 2023 May;41(5):1285-1291. doi: 10.1007/s00345-023-04371-6. Epub 2023 Mar 27. World J Urol. 2023. PMID: 36971827
Teaching robotic cystectomy: prospective pilot clinical validation of the ERUS training curriculum.
Diamand R, D'Hondt F, Mjaess G, Jabbour T, Dell'Oglio P, Larcher A, Moschini M, Quackels T, Peltier A, Assenmacher G, Wiklund P, Breda A, Turri F, De Groote R, Mottrie A, Roumeguere T, Albisinni S; ERUS Educational Working Group, the Junior ERUS/EAU-YAU Robotic Surgery Working Group and the EAU-YAU Urothelial Carcinoma Working Group. Diamand R, et al. Among authors: assenmacher g. BJU Int. 2023 Jul;132(1):84-91. doi: 10.1111/bju.15993. Epub 2023 Mar 26. BJU Int. 2023. PMID: 36815233
21 results